Device
BREATHE
BREATHE is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
completed375%
not_yet_recruiting125%
Recent Activity
0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable
Portable Positive Pressure Therapy Device
NCT04452851
completednot_applicable
BREATHE: Virtual Self-management for Long COVID-19
NCT05107440
completednot_applicable
Feasibility of the BREATHE Asthma Intervention Trial
NCT03036267
completednot_applicable
Evaluating an Internet-based Program for Anxious Adolescents
NCT02970734
Clinical Trials (4)
Showing 4 of 4 trials
NCT04452851Not Applicable
Portable Positive Pressure Therapy Device
NCT05107440Not Applicable
BREATHE: Virtual Self-management for Long COVID-19
NCT03036267Not Applicable
Feasibility of the BREATHE Asthma Intervention Trial
NCT02970734Not Applicable
Evaluating an Internet-based Program for Anxious Adolescents
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4